Stock listing
Prenetics Global Limited
Selected listing: PRE · NASDAQ · USD · US
Prenetics Global Limited (NASDAQ:PRE), Finance. Latest release Sep 4, 2026: Prenetics Global : Amendment to Annual Report by Foreign Issuer (Form 20-F/A).
- Ticker
- NASDAQ:PRE
- Asset type
- Stock
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- NASDAQ
- Currency
- USD
About Prenetics Global Limited
Prenetics Global Limited, trading under the ticker PRE, is a public company listed in the American market. Prenetics focuses on providing innovative genetic and diagnostic testing solutions.
Latest news from Prenetics Global Limited
Prenetics Global : Amendment to Annual Report by Foreign Issuer (Form 20-F/A)
September 4, 2026
Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
August 26, 2026
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
August 18, 2026
Prenetics Global : 2Q26 Letter to Shareholders
August 18, 2026
Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation
August 7, 2026
Events
Research Prenetics Global Limited
Prenetics Global Limited company profile
View the public company page for Prenetics Global Limited on 6ix.
Prenetics Global Limited news
Read company news and market updates connected to Prenetics Global Limited.
Prenetics Global Limited investor events
Find investor webinars, events, and replay context for Prenetics Global Limited.